FDA Approves Tezspire for Chronic Rhinosinusitis with Nasal Polyps
- 24 October 2025
 - 1 week ago
 
AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps
- 18 October 2025
 - 2 weeks ago
 
Oticara’s Intranasal Steroid Cream Achieves Phase 2 Success in Post-Surgical Chronic Rhinosinusitis
- 14 October 2025
 - 2 weeks ago
 
Aspirin therapy proved ineffective in treating chronic rhinosinusitis with nasal polyps: Study
- 30 September 2025
 - 1 month ago
 
Surgery to treat chronic sinus disease more effective than antibiotics, finds study
- 09 September 2025
 - 1 month ago
 
Dupilumab Associated With "Highly Favorable" Outcomes In Type 2 Chronic Rhinosinusitis
- 25 July 2025
 - 3 months ago
 
Recent News
Nanotechnology Reverses Alzheimer's Symptoms in Mi...
- 03 November, 2025
 
Gum disease could silently cause serious brain dam...
- 03 November, 2025
 
Can Early-Day Fasting Significantly Boost Metaboli...
- 03 November, 2025
 
Delhi HC bars doctor from running medical centre d...
- 03 November, 2025
 
Phase III data for Gazyva/Gazyvaro show significan...
- 03 November, 2025
 
Daily Newsletter
Get all the top stories from Blogs to keep track.
                    
                    





